APT Medical Inc (688617) - Cash Flow Conversion Efficiency
Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.093x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.68 Million ≈ $43.12 Million USD) by net assets (CN¥3.18 Billion ≈ $465.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688617 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
APT Medical Inc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
APT Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Masan Group Corp
VN:MSN
|
0.032x |
|
Cosan SA ADR
NYSE:CSAN
|
0.029x |
|
Travere Therapeutics Inc
NASDAQ:TVTX
|
-0.409x |
|
ExlService Holdings Inc
NASDAQ:EXLS
|
0.002x |
|
Caesars Entertainment Corporation
NASDAQ:CZR
|
0.080x |
|
Parq Arauco
SN:PARAUCO
|
0.027x |
|
Broadstone Net Lease Inc
NYSE:BNL
|
0.025x |
|
SOLV Energy, Inc. Class A Common Stock
NASDAQ:MWH
|
0.459x |
Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see how much is APT Medical Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.18 Billion ≈ $465.03 Million |
CN¥975.30 Million ≈ $142.72 Million |
0.307x | +5.47% |
| 2024-12-31 | CN¥2.55 Billion ≈ $373.85 Million |
CN¥743.39 Million ≈ $108.78 Million |
0.291x | -17.15% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.10 Million |
CN¥689.06 Million ≈ $100.83 Million |
0.351x | +71.18% |
| 2022-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥367.46 Million ≈ $53.77 Million |
0.205x | +102.58% |
| 2021-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥181.39 Million ≈ $26.54 Million |
0.101x | -69.25% |
| 2020-12-31 | CN¥450.09 Million ≈ $65.86 Million |
CN¥148.24 Million ≈ $21.69 Million |
0.329x | +107.52% |
| 2019-12-31 | CN¥345.90 Million ≈ $50.62 Million |
CN¥54.90 Million ≈ $8.03 Million |
0.159x | +130.60% |
| 2018-12-31 | CN¥270.70 Million ≈ $39.61 Million |
CN¥18.63 Million ≈ $2.73 Million |
0.069x | +14.29% |
| 2017-12-31 | CN¥214.43 Million ≈ $31.38 Million |
CN¥12.91 Million ≈ $1.89 Million |
0.060x | -- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more